A225220 Stock Overview
Genolution Inc. manufactures and sells IVD products in South Korea and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Genolution Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩3,970.00 |
| 52 Week High | ₩6,040.00 |
| 52 Week Low | ₩3,480.00 |
| Beta | 0.14 |
| 1 Month Change | 1.93% |
| 3 Month Change | 1.40% |
| 1 Year Change | -27.95% |
| 3 Year Change | -51.25% |
| 5 Year Change | 197.57% |
| Change since IPO | 167.31% |
Recent News & Updates
Shareholder Returns
| A225220 | KR Life Sciences | KR Market | |
|---|---|---|---|
| 7D | 4.5% | -0.8% | 2.2% |
| 1Y | -27.9% | 0.6% | 5.4% |
Return vs Industry: A225220 underperformed the KR Life Sciences industry which returned 2.2% over the past year.
Return vs Market: A225220 underperformed the KR Market which returned 4.5% over the past year.
Price Volatility
| A225220 volatility | |
|---|---|
| A225220 Average Weekly Movement | 3.9% |
| Life Sciences Industry Average Movement | 7.4% |
| Market Average Movement | 5.2% |
| 10% most volatile stocks in KR Market | 11.7% |
| 10% least volatile stocks in KR Market | 2.4% |
Stable Share Price: A225220 has not had significant price volatility in the past 3 months.
Volatility Over Time: A225220's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2006 | n/a | Ki-Ok Kim | www.genolution1.com |
Genolution Inc. manufactures and sells IVD products in South Korea and internationally. Its products are primarily focused on molecular diagnostics, ribonucleic acid interference (RNAi) services, and dsRNA research for the prevention of breeding and extermination. The company offers Nextractor, an automatic extraction system for isolation of DNA or RNA from various samples; and FFPE, whole blood, buccal swab, RV, TB/NTM, STD, HPV, HBV, and CMV/EBV extraction kits, as well as rice, plant, and cell extraction kits.
Genolution Inc. Fundamentals Summary
| A225220 fundamental statistics | |
|---|---|
| Market cap | ₩76.18b |
| Earnings (TTM) | -₩4.72b |
| Revenue (TTM) | ₩11.33b |
6.7x
P/S Ratio-16.2x
P/E RatioIs A225220 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A225220 income statement (TTM) | |
|---|---|
| Revenue | ₩11.33b |
| Cost of Revenue | ₩5.20b |
| Gross Profit | ₩6.14b |
| Other Expenses | ₩10.85b |
| Earnings | -₩4.72b |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -245.82 |
| Gross Margin | 54.14% |
| Net Profit Margin | -41.62% |
| Debt/Equity Ratio | 20.5% |
How did A225220 perform over the long term?
See historical performance and comparison